首页|血清D-二聚体、FIB联合检测对妊娠期高血压综合征的早期预测价值

血清D-二聚体、FIB联合检测对妊娠期高血压综合征的早期预测价值

扫码查看
目的 探究血清D-二聚体(D-D)、纤维蛋白原(FIB)联合检测对妊娠期高血压综合征的早期预测价值。方法 选取100例妊娠期高血压综合征孕妇作为观察组,其中妊娠期高血压64例(妊娠期高血压组),轻度子痫前期22例(轻度子痫前期组),重度子痫前期14例(重度子痫前期组);另选取产前体检的健康孕妇100例作为对照组。检测并比较四组孕妇凝血功能相关指标[FIB、凝血酶时间(TT)、抗凝血酶Ⅲ(AT-Ⅲ)、凝血酶原时间(PT)、凝血酶原时间-国际标准化比值(PT-INR)、活化部分凝血活酶时间(ATPP)]、D-D、纤溶相关指标[组织型纤溶酶原活化因素(tPA)和纤溶酶原激活抑制物-1(PAI-1)]。结果 四组FIB、AT-Ⅲ、PT、PT-INR、APTT比较,差异有统计学意义(P<0。05);妊娠期高血压组、轻度子痫前期组和重度子痫前期组孕妇AT-Ⅲ、PT、PT-INR和APTT均低于对照组,FIB高于对照组,差异有统计学意义(P<0。05)。妊娠期高血压组D-D、tPA、PAI-1分别为(289。59±25。26)μg/L、(8。15±0。74)U/ml、(37。85±5。06)ng/ml,轻度子痫前期组分别为(357。15±26。69)μg/L、(8。69±0。56)U/ml、(38。48±5。53)ng/ml,重度子痫前期组分别为(428。48±27。26)μg/L、(9。08±0。32)U/ml、(51。48±6。26)ng/ml,对照组分别为(244。26±22。26)μg/L、(7。32±0。74)U/ml、(14。06±4。26)ng/ml;妊娠期高血压组、轻度子痫前期组、重度子痫前期组孕妇D-D、tPA、PAI-1水平均高于对照组,差异有统计学意义(P<0。05)。结论 妊娠期高血压监测血清D-D、FIB等相关指标水平可及时发现凝血纤溶功能异常,且病情越严重则上述指标变化越明显,对临床妊娠期高血压综合征的预测和治疗提供合理依据,值得应用。
The value of combined detection of serum D-dimer and FIB in early prediction of pregnancy-induced hypertension syndrome
Objective To investigate the value of combined detection of serum D-dimer (D-D) and fibrinogen (FIB) in early prediction of pregnancy-induced hypertension syndrome. Methods 100 cases of pregnant women with pregnancy-induced hypertension syndrome were selected as the observation group,including 64 cases of gestational hypertension (gestational hypertension group),22 cases of mild preeclampsia (mild preeclampsia group),and 14 cases of severe preeclampsia (severe preeclampsia group);and another 100 cases of healthy pregnant women with prenatal examination were selected as the control group. The coagulation-related indexes[FIB,thrombin time (TT),antithrombin Ⅲ (AT-Ⅲ),prothrombin time (PT),prothrombin time-international normalized ratio (PT-INR),activated partial thromboplastin time (ATPP)],D-D,fibrinolysis-related indexes[tissue-type plasminogen activator (tPA) and plasminogen activator inhibitor-1 (PAI-1)]were tested and compared among the four groups. Results Comparison of FIB,AT-Ⅲ,PT,PT-INR and APTT among the four groups showed statistically significant differences (P<0.05). AT-Ⅲ,PT,PT-INR and APTT of gestational hypertension group,mild preeclampsia group and severe preeclampsia group were lower than those of the control group,and FIB was higher than that of the control group. The difference was statistically significant (P<0.05). In gestational hypertension group,D-D,tPA and PAI-1 levels were (289.59±25.26) μg/L,(8.15±0.74) U/ml and (37.85±5.06) ng/ml;in mild preeclampsia group,those were (357.15±26.69) μg/L,(8.69±0.56) U/ml and (38.48±5.53) ng/ml;in severe preeclampsia group,those were (428.48±27.26) μg/L,(9.08±0.32) U/ml and (51.48±6.26) ng/ml;in control group,those were (244.26±22.26) μg/L,(7.32±0.74) U/ml and (14.06±4.26) ng/ml. The levels of D-D,tPA and PAI-1 in gestational hypertension group,mild preeclampsia group and severe preeclampsia group were higher than those in the control group,and the differences were statistically significant (P<0.05). Conclusion Monitoring the levels of serum D-D,FIB and other related indexes of pregnant women with pregnancy-induced hypertension can find the abnormal coagulation and fibrinolysis function in time,and the more serious the condition is,the more obvious the changes of the above indexes are,which provides a reasonable basis for the prediction and treatment of clinical pregnancy-induced hypertension syndrome,and is worthy of application.

Serum D-dimerFibrinogenPregnancy-induced hypertension syndromeEarly prediction

张淑花、王妙翩

展开 >

362000 泉州市鲤城区江南街道社区卫生服务中心检验科

血清D-二聚体 纤维蛋白原 妊娠期高血压综合征 早期预测

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(20)